First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis
13 févr. 2020 07h00 HE
|
Laboratoris Sanifit S.L.
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (CUA) or calciphylaxis ...
Laboratoris Sanifit S.L.: Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
23 oct. 2018 07h00 HE
|
Laboratoris Sanifit S.L.
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris...
Laboratoris Sanifit S.L.: Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology
23 oct. 2018 02h00 HE
|
Laboratoris Sanifit S.L.
Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris...